Former CEO of Sirtex Medical Limited charged with insider trading

insider trading

Mr Gilman Edwin Wong, the former Chief Executive Officer and director of Sirtex Medical Limited, appeared yesterday at the Downing Central Local Court in Sydney charged with one count of insider trading under the Corporations Act, Australian regulator ASIC informed earlier today.

ASIC alleges that Mr Wong was in possession of inside information, concerning Sirtex’s sales, when he sold 74,698 shares in Sirtex on 26 October 2016.

The matter was adjourned to 20 November 2018.

The maximum penalty for an insider trading offence is 10 years’ imprisonment.

The matter is being prosecuted by the Commonwealth Director of Public Prosecutions.

Read Also: